Index S&P 500 P/E 11.79 EPS (ttm) 23.49 Insider Own 0.17% Shs Outstand 225.94M Perf Week -18.66%
Market Cap 62.60B Forward P/E 7.88 EPS next Y 35.17 Insider Trans -0.01% Shs Float 225.56M Perf Month -26.15%
Enterprise Value - PEG 2.02 EPS next Q 6.76 Inst Own 92.82% Short Float 1.13% Perf Quarter -36.31%
Income 5.36B P/S 0.33 EPS this Y -2.40% Inst Trans -1.47% Short Ratio 1.36 Perf Half Y -28.82%
Sales 189.25B P/B 1.42 EPS next Y 9.06% ROA 4.56% Short Interest 2.54M Perf YTD -24.89%
Book/sh 194.46 P/C - EPS next 5Y 5.85% ROE 12.48% 52W High 567.26 -51.15% Perf Year -49.91%
Cash/sh - P/FCF 11.73 EPS past 3/5Y 1.26% 6.81% ROIC 7.45% 52W Low 296.39 -6.51% Perf 3Y -41.13%
Dividend Est. 6.76 (2.44%) EV/EBITDA - Sales past 3/5Y 8.44% 11.15% Gross Margin - Volatility 5.15% 3.13% Perf 5Y 7.57%
Dividend TTM 6.68 (2.41%) EV/Sales - EPS Y/Y TTM -17.79% Oper. Margin 4.46% ATR (14) 13.77 Perf 10Y 73.47%
Dividend Ex-Date Jun 10, 2025 Quick Ratio - Sales Y/Y TTM 10.21% Profit Margin 2.83% RSI (14) 19.12 Recom 1.71
Dividend Gr. 3/5Y 12.99% 15.30% Current Ratio 1.44 EPS Q/Q -21.67% SMA20 -21.55% Beta 0.60 Target Price 413.17
Payout 25.39% Debt/Eq 0.69 Sales Q/Q 14.04% SMA50 -25.98% Rel Volume 4.47 Prev Close 302.45
Employees 104200 LT Debt/Eq 0.64 Earnings Jul 17 BMO SMA200 -31.37% Avg Volume 1.87M Price 277.09
IPO Oct 30, 2001 Option/Short Yes / Yes EPS/Sales Surpr. -0.78% 2.55% Trades
Volume 8,373,850 Change -8.38%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-18-25 Downgrade Leerink Partners
Outperform → Market Perform
$310
Apr-15-25 Downgrade Robert W. Baird
Outperform → Neutral
$529
Mar-17-25 Upgrade Argus
Hold → Buy
$450
Jan-22-25 Downgrade Stephens
Overweight → Equal-Weight
$520 → $440
Oct-18-24 Downgrade Argus
Buy → Hold
Jul-18-24 Downgrade BofA Securities
Buy → Neutral
$646 → $530
Jun-24-24 Initiated Morgan Stanley
Overweight
$643
May-30-24 Initiated Robert W. Baird
Outperform
$649
Mar-06-24 Initiated Barclays
Overweight
$584
Jul-12-23 Downgrade Wolfe Research
Outperform → Peer Perform
Apr-27-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$500 → $571
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$547
Mar-28-23 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$523 → $572
Sep-09-22 Upgrade BofA Securities
Neutral → Buy
$535 → $575
Aug-22-22 Upgrade SVB Leerink
Mkt Perform → Outperform
$490 → $580
Show Previous Ratings
Jul-18-25 04:33PM
01:38PM
11:24AM
11:00AM
10:28AM
(The Wall Street Journal)
09:52AM
Loading…
09:52AM
09:39AM
(The Wall Street Journal)
09:38AM
09:16AM
08:50AM
08:34AM
06:03AM
03:07AM
01:32AM
Jul-17-25 05:04PM
(The Wall Street Journal) -12.22%
05:01PM
Loading…
05:01PM
04:44PM
04:38PM
03:59PM
03:46PM
02:43PM
01:57PM
01:24PM
(The Wall Street Journal)
01:21PM
01:21PM
11:58AM
10:46AM
10:38AM
10:11AM
10:09AM
09:30AM
Loading…
09:30AM
07:51AM
06:40AM
06:32AM
06:09AM
(Associated Press Finance)
06:00AM
Jul-15-25 11:04PM
05:30PM
04:32PM
03:43PM
10:01AM
Jul-14-25 11:08AM
09:15AM
Jul-10-25 11:14AM
11:13AM
10:00AM
05:30AM
(The Wall Street Journal)
Jul-09-25 02:25PM
Jul-08-25 07:02AM
Jul-07-25 09:20AM
Jul-06-25 03:35AM
Jul-02-25 07:35PM
(Morningstar Research) -11.50%
04:15PM
03:05PM
08:54AM
(Investor's Business Daily)
08:37AM
07:09AM
Jul-01-25 09:32AM
Jun-30-25 10:27AM
Jun-29-25 12:53PM
Jun-27-25 11:36AM
08:01AM
Jun-24-25 02:05PM
09:20AM
08:39AM
Jun-23-25 06:28AM
Jun-18-25 06:20AM
Jun-17-25 11:18AM
11:15AM
08:07AM
Jun-15-25 11:36PM
05:39AM
Jun-12-25 08:01AM
Jun-11-25 11:39AM
12:01AM
Jun-03-25 10:28AM
Jun-02-25 09:03AM
06:11AM
May-28-25 09:11AM
May-23-25 11:13AM
May-22-25 04:55PM
04:45PM
11:30AM
May-19-25 05:07PM
May-15-25 11:05AM
10:06AM
May-12-25 08:55AM
May-07-25 10:44PM
09:00AM
May-06-25 01:25PM
May-02-25 11:05AM
(The Wall Street Journal)
May-01-25 05:55PM
02:53PM
(The Wall Street Journal)
02:04PM
Apr-30-25 12:57PM
11:30AM
10:30AM
Apr-29-25 10:59AM
03:08AM
02:01AM
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BOUDREAUX GAIL President and CEO Jul 18 '25 Buy 286.94 8,500 2,438,951 151,020 Jul 18 01:42 PM Kaye Mark EVP & CFO Apr 24 '25 Sale 424.82 4,588 1,949,074 18,977 Apr 25 04:17 PM Kaye Mark Officer Apr 24 '25 Proposed Sale 424.81 4,588 1,949,051 Apr 24 05:10 PM Penczek Ronald W CAO & Controller Mar 10 '25 Sale 415.13 443 183,903 1,847 Mar 11 04:20 PM Penczek Ronald W Officer Mar 10 '25 Proposed Sale 415.13 443 183,904 Mar 10 02:55 PM Kendrick Charles Morgan JR EVP & President, Commercial Mar 05 '25 Sale 396.30 3,504 1,388,635 10,116 Mar 05 05:52 PM Kendrick Charles Morgan JR Officer Mar 05 '25 Proposed Sale 396.30 3,504 1,388,651 Mar 05 05:19 PM Kendrick Charles Morgan JR EVP & President, Commercial Oct 18 '24 Sale 432.14 7,417 3,205,182 8,423 Oct 18 05:21 PM Kendrick Charles Morgan JR Director Oct 18 '24 Proposed Sale 432.28 7,417 3,206,221 Oct 18 01:48 PM PERU RAMIRO G Director Aug 05 '24 Sale 531.52 753 400,235 8,744 Aug 06 05:23 PM RAMIRO G PERU Director Aug 05 '24 Proposed Sale 531.52 753 400,235 Aug 05 04:14 PM BOUDREAUX GAIL President and CEO Jul 22 '24 Sale 500.98 34,000 17,033,395 126,709 Jul 23 05:02 PM
